Bank of America Corp DE Buys 360,372 Shares of Liquidia Corporation $LQDA

Posted by Francis Steltz on Aug 9th, 2026

Bank of America Corp DE raised its stake in Liquidia Corporation (NASDAQ:LQDA – Free Report) by 18.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,287,792 shares of the company’s stock after acquiring an additional 360,372 shares during the quarter. Bank of America Corp DE’s holdings in Liquidia were worth $86,341,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Covestor Ltd increased its stake in shares of Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after purchasing an additional 359 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Liquidia by 7.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after purchasing an additional 422 shares during the period. Quantinno Capital Management LP lifted its stake in Liquidia by 3.6% in the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after purchasing an additional 589 shares during the last quarter. Northwestern Mutual Wealth Management Co. purchased a new position in Liquidia in the fourth quarter valued at approximately $25,000. Finally, ProShare Advisors LLC grew its holdings in Liquidia by 7.1% during the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after purchasing an additional 775 shares during the period. 64.54% of the stock is owned by institutional investors.

Liquidia Stock Performance

Shares of LQDA stock opened at $90.22 on Friday. The firm’s 50 day moving average is $76.45 and its 200 day moving average is $53.69. The stock has a market capitalization of $8.02 billion, a P/E ratio of 644.47 and a beta of 0.58. Liquidia Corporation has a 12 month low of $19.02 and a 12 month high of $91.57. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18.

Liquidia (NASDAQ:LQDA – Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business had revenue of $132.87 million during the quarter, compared to analyst estimates of $119.44 million. The firm’s quarterly revenue was up 4187.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Liquidia Corporation will post 3.02 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on LQDA shares. Oppenheimer set a $75.00 target price on Liquidia in a research report on Friday, June 5th. Jefferies Financial Group reaffirmed a “buy” rating and set a $60.00 price target on shares of Liquidia in a research report on Monday, May 11th. Stephens set a $130.00 price target on Liquidia in a research note on Friday, July 24th. Raymond James Financial reissued a “strong-buy” rating and issued a $68.00 price objective on shares of Liquidia in a report on Thursday, June 4th. Finally, Zacks Research upgraded Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $86.18.

Read Our Latest Stock Report on LQDA

Insider Activity

In other news, Director Stephen M. Bloch sold 100,000 shares of the firm’s stock in a transaction on Thursday, July 23rd. The stock was sold at an average price of $89.48, for a total value of $8,948,000.00. Following the completion of the transaction, the director directly owned 501,477 shares of the company’s stock, valued at $44,872,161.96. This trade represents a 16.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Dana Boyle sold 1,600 shares of Liquidia stock in a transaction on Monday, July 27th. The shares were sold at an average price of $87.53, for a total value of $140,048.00. Following the completion of the transaction, the chief accounting officer owned 167,919 shares of the company’s stock, valued at approximately $14,697,950.07. This trade represents a 0.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 2,150,754 shares of company stock valued at $142,869,858. 25.60% of the stock is currently owned by corporate insiders.

About Liquidia

(Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).